PureTech Health PLC Net Income
| PRTC Stock | USD 18.69 0.42 2.20% |
As of the 3rd of February, PureTech Health holds the Risk Adjusted Performance of 0.0379, semi deviation of 2.51, and Coefficient Of Variation of 2412.15. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of PureTech Health, as well as the relationship between them.
PureTech Health Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 22.7655 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income | 31.9 M | 33.5 M | |
| Net Income From Continuing Ops | 31.9 M | 33.5 M | |
| Net Loss | -69.6 M | -66.2 M | |
| Net Income Per Share | 1.79 | 1.88 | |
| Net Income Per E B T | 2.03 | 2.13 |
PureTech | Net Income | Build AI portfolio with PureTech Stock |
Analyzing PureTech Health's Net Income over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Net Income has evolved provides context for assessing PureTech Health's current valuation and future prospects.
Latest PureTech Health's Net Income Growth Pattern
Below is the plot of the Net Income of PureTech Health PLC over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in PureTech Health PLC financial statement analysis. It represents the amount of money remaining after all of PureTech Health PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is PureTech Health's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in PureTech Health's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 27.78 M | 10 Years Trend |
|
Net Income |
| Timeline |
PureTech Net Income Regression Statistics
| Arithmetic Mean | 14,711,813 | |
| Coefficient Of Variation | 767.47 | |
| Mean Deviation | 65,660,442 | |
| Median | (11,054,000) | |
| Standard Deviation | 112,908,384 | |
| Sample Variance | 12748.3T | |
| Range | 486.8M | |
| R-Value | 0.17 | |
| Mean Square Error | 13182.3T | |
| R-Squared | 0.03 | |
| Significance | 0.50 | |
| Slope | 3,910,226 | |
| Total Sum of Squares | 203972.9T |
PureTech Net Income History
Other Fundumenentals of PureTech Health PLC
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
PureTech Health Net Income component correlations
PureTech Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for PureTech Health is extremely important. It helps to project a fair market value of PureTech Stock properly, considering its historical fundamentals such as Net Income. Since PureTech Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of PureTech Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of PureTech Health's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could PureTech diversify its offerings? Factors like these will boost the valuation of PureTech Health. Anticipated expansion of PureTech directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PureTech Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.615 | Earnings Share 1.7 | Revenue Per Share | Quarterly Revenue Growth 5.427 | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PureTech Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PureTech Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PureTech Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
PureTech Health 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to PureTech Health's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of PureTech Health.
| 11/05/2025 |
| 02/03/2026 |
If you would invest 0.00 in PureTech Health on November 5, 2025 and sell it all today you would earn a total of 0.00 from holding PureTech Health PLC or generate 0.0% return on investment in PureTech Health over 90 days. PureTech Health is related to or competes with Autolus Therapeutics, Neurogene, Solid Biosciences, QuantumSi, Lineage Cell, Benitec Biopharma, and ADC Therapeutics. PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inf... More
PureTech Health Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure PureTech Health's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess PureTech Health PLC upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.33 | |||
| Information Ratio | 0.0222 | |||
| Maximum Drawdown | 14.71 | |||
| Value At Risk | (4.58) | |||
| Potential Upside | 4.53 |
PureTech Health Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for PureTech Health's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as PureTech Health's standard deviation. In reality, there are many statistical measures that can use PureTech Health historical prices to predict the future PureTech Health's volatility.| Risk Adjusted Performance | 0.0379 | |||
| Jensen Alpha | 0.1528 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0194 | |||
| Treynor Ratio | (0.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of PureTech Health's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
PureTech Health February 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0379 | |||
| Market Risk Adjusted Performance | (0.11) | |||
| Mean Deviation | 1.96 | |||
| Semi Deviation | 2.51 | |||
| Downside Deviation | 3.33 | |||
| Coefficient Of Variation | 2412.15 | |||
| Standard Deviation | 2.9 | |||
| Variance | 8.41 | |||
| Information Ratio | 0.0222 | |||
| Jensen Alpha | 0.1528 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | 0.0194 | |||
| Treynor Ratio | (0.12) | |||
| Maximum Drawdown | 14.71 | |||
| Value At Risk | (4.58) | |||
| Potential Upside | 4.53 | |||
| Downside Variance | 11.1 | |||
| Semi Variance | 6.31 | |||
| Expected Short fall | (2.27) | |||
| Skewness | 0.3642 | |||
| Kurtosis | 2.27 |
PureTech Health PLC Backtested Returns
PureTech Health appears to be not too volatile, given 3 months investment horizon. PureTech Health PLC maintains Sharpe Ratio (i.e., Efficiency) of 0.0696, which implies the firm had a 0.0696 % return per unit of risk over the last 3 months. We have found thirty technical indicators for PureTech Health PLC, which you can use to evaluate the volatility of the company. Please evaluate PureTech Health's Coefficient Of Variation of 2412.15, semi deviation of 2.51, and Risk Adjusted Performance of 0.0379 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, PureTech Health holds a performance score of 5. The company holds a Beta of -0.93, which implies possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning PureTech Health are expected to decrease slowly. On the other hand, during market turmoil, PureTech Health is expected to outperform it slightly. Please check PureTech Health's expected short fall, and the relationship between the value at risk and daily balance of power , to make a quick decision on whether PureTech Health's historical price patterns will revert.
Auto-correlation | 0.18 |
Very weak predictability
PureTech Health PLC has very weak predictability. Overlapping area represents the amount of predictability between PureTech Health time series from 5th of November 2025 to 20th of December 2025 and 20th of December 2025 to 3rd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of PureTech Health PLC price movement. The serial correlation of 0.18 indicates that over 18.0% of current PureTech Health price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.18 | |
| Spearman Rank Test | 0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 0.89 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
PureTech Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, PureTech Health PLC reported net income of 27.78 M. This is 91.86% lower than that of the Biotechnology sector and 60.34% lower than that of the Health Care industry. The net income for all United States stocks is 95.13% higher than that of the company.
PureTech Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PureTech Health's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PureTech Health could also be used in its relative valuation, which is a method of valuing PureTech Health by comparing valuation metrics of similar companies.PureTech Health is currently under evaluation in net income category among its peers.
PureTech Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of PureTech Health from analyzing PureTech Health's financial statements. These drivers represent accounts that assess PureTech Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of PureTech Health's important valuation drivers and their relationship over time.
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Market Cap | 1.6B | 1.1B | 892.4M | 778.6M | 700.8M | 643.9M | |
| Enterprise Value | 1.3B | 647.4M | 789.4M | 612.9M | 551.6M | 528.1M |
PureTech Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, PureTech Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to PureTech Health's managers, analysts, and investors.Environmental | Governance | Social |
PureTech Health Institutional Holders
Institutional Holdings refers to the ownership stake in PureTech Health that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of PureTech Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing PureTech Health's value.| Shares | Birch Hill Investment Advisors Llc | 2025-06-30 | 242.7 K | Pentwater Capital Management Lp | 2025-06-30 | 50 K | Portolan Capital Management, Llc | 2025-06-30 | 27.8 K | Millennium Management Llc | 2025-06-30 | 23.9 K | Diadema Partners Lp | 2025-06-30 | 7.3 K | Persistent Asset Partners Limited | 2025-06-30 | 1.7 K | Atlantic Union Bankshares Corp | 2025-06-30 | 115 | Ubs Group Ag | 2025-06-30 | 20.0 | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 0.0 |
PureTech Fundamentals
| Return On Equity | 0.0944 | ||||
| Return On Asset | -0.13 | ||||
| Profit Margin | 7.93 % | ||||
| Operating Margin | (25.90) % | ||||
| Current Valuation | 140.37 M | ||||
| Shares Outstanding | 24.17 M | ||||
| Shares Owned By Institutions | 0.42 % | ||||
| Number Of Shares Shorted | 4.75 K | ||||
| Price To Book | 1.23 X | ||||
| Price To Sales | 70.68 X | ||||
| Revenue | 4.83 M | ||||
| Gross Profit | (48.81 M) | ||||
| EBITDA | 37.38 M | ||||
| Net Income | 27.78 M | ||||
| Cash And Equivalents | 368.03 M | ||||
| Cash Per Share | 12.84 X | ||||
| Total Debt | 22.36 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 2.54 X | ||||
| Book Value Per Share | 1.56 X | ||||
| Cash Flow From Operations | (134.37 M) | ||||
| Short Ratio | 2.84 X | ||||
| Earnings Per Share | 1.70 X | ||||
| Target Price | 46.0 | ||||
| Number Of Employees | 56 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 451.71 M | ||||
| Total Asset | 602.63 M | ||||
| Retained Earnings | 32.49 M | ||||
| Working Capital | 344.87 M | ||||
| Net Asset | 602.63 M |
About PureTech Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PureTech Health PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PureTech Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PureTech Health PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether PureTech Health PLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PureTech Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Puretech Health Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Puretech Health Plc Stock:Check out You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Will Biotechnology sector continue expanding? Could PureTech diversify its offerings? Factors like these will boost the valuation of PureTech Health. Anticipated expansion of PureTech directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every PureTech Health data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.615 | Earnings Share 1.7 | Revenue Per Share | Quarterly Revenue Growth 5.427 | Return On Assets |
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between PureTech Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding PureTech Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, PureTech Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.